How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| NVIDIA Corp. | €155.68 | €185.74 |
| Rheinmetall AG | €1,497.5 | €2,000.0 |
| Amazon.com Inc. | €198.84 | €236.57 |
| Security | Price | Target price |
|---|---|---|
| Tesla Inc | €361.10 | €388.62 |
| thyssenkrupp AG | €9.04 | €10.00 |
| Arbor Realty Trust Inc. | €7.87 | - |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B DroneShield Ltd | StockLoan66 | 40.26% |
| B Arrowhead Pharmaceuticals Inc. | Royal Bank of Canada | 34.89% |
| B DroneShield Ltd | SwingFalcon94 | 26.25% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Safe & Green Holdings Corp. | blaugold | -40.90% |
| S Greenpower Motor Company Inc. | Lokrim | -29.20% |
| S Capricor Therapeutics Inc | BiotechBee | -20.58% |
Portfolios of our members
Humanoid Global Holdings Corp.
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
Cohen & Steers Inc.
WKN: A0B7TN / Symbol: CNS / Name: Cohen & Steers / Stock / Investment Banking & Investment Services / Mid Cap /
Pros
Cons
Sol Strategies Inc.
WKN: A41B77 / Name: Sol Strategies Inc. / Stock / ? /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Kohl's Corp. | €20.72 | 6.950% |
| Discovery Communications C | €22.42 | 5.110% |
| PVH Corp. | €71.00 | 5.000% |
| Lennar Corp. A | €113.36 | 4.760% |
| Bath & Body Works Inc. | €15.26 | 4.360% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Deere Co. | €408.85 | -5.110% |
| NetApp Inc. | €92.95 | -3.660% |
| Intuit Inc. | €542.30 | -3.230% |
| Salesforce.com | €196.12 | -3.100% |
| HP Inc. | €20.39 | -2.970% |
Courses
sharewise Introduction
Key figures for stocks
Predictions
Top News
5 Stocks to Buy Before Santa Claus Comes to Town
November was a challenging month for stocks, as macroeconomic concerns and concerns about an AI bubble weighed on prices. Most S&P 500 (NYSEARCA: SPY) stocks moved lower, but there is good news
History Says These are 3 Stocks to Buy for December
A popular holiday song touts December as “the most wonderful time of the year.” This is especially true for investors, as in the last 20 years, the S&P 500 index has moved higher in December 75%
Warner Bros. Sale Rumors Heat Up: What Investors Need to Know
While many stocks have come under considerable pressure over the past month, entertainment giant Warner Bros. Discovery (NASDAQ: WBD) continues trudging higher. As of the Nov. 24 close, shares are
From Science Project to Solvent: WeRide’s 761% Revenue Surge
For years, the autonomous vehicle (AV) sector has been defined by a frustrating narrative of high cash burn and distant promises. Investors have watched billions of dollars vanish into research
Will the S&P 500 Rally in December? These 3 Signals Point to a Big Move Ahead
Risks remain, but the S&P 500’s (NYSEARCA: SPY) uptrend is intact. The November correction was more of a broad-market consolidation, setting the market up for another leg of the rally, likely to
Wall Street Analysts Believe Abacus Life, Inc. (ABL) Could Rally 110.27%: Here's is How to Trade
Abacus Life, Inc. (ABL) closed the last trading session at $6.23, gaining 17.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts Believe Crexendo (CXDO) Could Rally 27.87%: Here's is How to Trade
Shares of Crexendo (CXDO) have gained 8.6% over the past four weeks to close the last trading session at $6.96, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts Believe Compass Therapeutics, Inc. (CMPX) Could Rally 154.09%: Here's is How to Trade
Shares of Compass Therapeutics, Inc. (CMPX) have gained 22.2% over the past four weeks to close the last trading session at $5.01, but there could still be a solid upside left in the stock if
Wall Street Analysts Think Amicus Therapeutics (FOLD) Could Surge 58.46%: Read This Before Placing a Bet
Amicus Therapeutics (FOLD) closed the last trading session at $9.87, gaining 11.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Does SkyWest (SKYW) Have the Potential to Rally 34.49% as Wall Street Analysts Expect?
Shares of SkyWest (SKYW) have gained 0.7% over the past four weeks to close the last trading session at $99.34, but there could still be a solid upside left in the stock if short-term price targets
"You will be much more in control, if you realize how much you are not in control." --Benjamin Graham
TAX-LOSS POUNCING
TAX-LOSS POUNCING (November 23, 2025): I am sure that by this time you have either heard from your accountant or read numerous articles about how you can save
News
Wall Street Analysts Think PRA Group (PRAA) Could Surge 41.95%: Read This Before Placing a Bet
PRA Group (PRAA) closed the last trading session at $15.97, gaining 9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
How Much Upside is Left in Keros Therapeutics (KROS)? Wall Street Analysts Think 34.24%
Shares of Keros Therapeutics, Inc. (KROS) have gained 14.1% over the past four weeks to close the last trading session at $17.32, but there could still be a solid upside left in the stock if
Should You Buy PLBY Group, Inc. (PLBY) After Golden Cross?
From a technical perspective, PLBY Group, Inc. (PLBY) is looking like an interesting pick, as it just reached a key level of support. PLBY's 50-day simple moving average crossed above its 200-day
Wall Street Analysts Believe Pharming Group (PHAR) Could Rally 81.71%: Here's is How to Trade
Shares of Pharming Group N.V. Sponsored ADR (PHAR) have gained 24% over the past four weeks to close the last trading session at $17.06, but there could still be a solid upside left in the stock if
Wall Street Analysts Think OrthoPediatrics (KIDS) Could Surge 26.45%: Read This Before Placing a Bet
Shares of OrthoPediatrics (KIDS) have gained 12.9% over the past four weeks to close the last trading session at $19.09, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts Predict a 46.55% Upside in Life Time Group Holdings (LTH): Here's What You Should Know
Life Time Group Holdings, Inc. (LTH) closed the last trading session at $27.54, gaining 7.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Wall Street Analysts See a 126.21% Upside in Immuneering (IMRX): Can the Stock Really Move This High?
Shares of Immuneering Corporation (IMRX) have gained 14.6% over the past four weeks to close the last trading session at $7.44, but there could still be a solid upside left in the stock if
Bears are Losing Control Over ClearSign (CLIR), Here's Why It's a 'Buy' Now
Shares of ClearSign Technologies (CLIR) have been struggling lately and have lost 8.9% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean
Wall Street Analysts Believe Orion Energy Systems (OESX) Could Rally 26.36%: Here's is How to Trade
Orion Energy Systems, Inc. (OESX) closed the last trading session at $14.11, gaining 41.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Contest
Still running
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.










